AB8939, Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets
AB18001
Phase 2 small_molecule active
Quick answer
AB8939, Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AB Science
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active